Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?
Eur Urol Open Sci
.
2021 Jun 26:30:44-46.
doi: 10.1016/j.euros.2021.06.006.
eCollection 2021 Aug.
Authors
Adi Kartolo
1
,
Giuseppe Procopio
2
,
Francisco E Vera-Badillo
1
Affiliations
1
Division of Medical Oncology, Department of Oncology, Queen's University, Kingston, Ontario, Canada.
2
Dipartimento di Oncologia Medica, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
PMID:
34337547
PMCID:
PMC8317808
DOI:
10.1016/j.euros.2021.06.006
No abstract available
Publication types
Editorial